RECRUITING

Optimal Intervention to Full Viral Suppression: Text Me, Alexis!

Description

Text Me, Alexis! is a three-arm randomized controlled trial (RCT) to determine the optimal and most cost-effective intervention for advancing trans women living with HIV to full viral suppression. Participants will be randomized (1:1:1) to Peer Health Navigation (PHN) alone, SMS (text messaging) alone, or PHN+SMS. Participants in the PHN alone and PHN+SMS arms will receive unlimited navigation sessions over 3 months. Participants in the SMS alone and PHN+SMS arms will receive 3 daily theory-based text messages for 90 days for a total of 270 unique scripted messages.

Conditions

HIV
Talk to us

Related Conditions:

HIV

Study Overview

On this page

Study Details

Study overview

Text Me, Alexis! is a three-arm randomized controlled trial (RCT) to determine the optimal and most cost-effective intervention for advancing trans women living with HIV to full viral suppression. Participants will be randomized (1:1:1) to Peer Health Navigation (PHN) alone, SMS (text messaging) alone, or PHN+SMS. Participants in the PHN alone and PHN+SMS arms will receive unlimited navigation sessions over 3 months. Participants in the SMS alone and PHN+SMS arms will receive 3 daily theory-based text messages for 90 days for a total of 270 unique scripted messages.

Comparative- and Cost-effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women Living With HIV to Full Viral Suppression

Optimal Intervention to Full Viral Suppression: Text Me, Alexis!

Condition
HIV
Intervention / Treatment

-

Contacts and Locations

Los Angeles

Friends Community Center, Los Angeles, California, United States, 90028

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Self-identified transgender woman;
  • * Age 18 or older;
  • * Verified HIV positive status;
  • * Not currently in HIV care, and/or had not had an HIV care visit in the previous 6 months, and/or had a viral load of ≥200 copies/ml on her last lab test result, and/or not currently prescribed ART, and/or prescribed ART but does not rate her ability to take all her medications as "excellent";
  • * Ability to receive daily text messages on either a personal cell phone or via an email account
  • * Does not identify as a transgender woman;
  • * Under 18 years of age;
  • * HIV negative status;
  • * Currently in HIV care, and had a HIV care visit in the previous 6 months, and had a viral load of ≤200 copies/ml on her last lab test result, and currently prescribed ART, and rates her ability to take all her medications as "excellent";
  • * Does not have the ability to receive daily text messages on either a personal cell phone or via an email account.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Friends Research Institute, Inc.,

Cathy J Reback, PhD, PRINCIPAL_INVESTIGATOR, Friends Research Institute, Inc.

Sean M Murphy, PhD, PRINCIPAL_INVESTIGATOR, Weill Medical College of Cornell University

Study Record Dates

2027-03-31